Paras Healthcare Ipo
Paras Healthcare IPO Review & Key Points
Review:
IPO Lead Managers aka Merchant Bankers
ICICI Securities Limited
Iifl Securities Ltd
Motilal Oswal Investment Advisors Limited
| Application | Lot Size | Shares | Amount |
| Retail Minimum | – | – | ₹- |
| Retail Maximum | – | – | ₹- |
| S-HNI Minimum | – | – | ₹- |
| S-HNI Maximum | – | – | ₹- |
| B-HNI Minimum | – | – | ₹- |
| Investor Category | Share Offered | -% Shares |
| Anchor Investor | – Shares | -% |
| QIB (Ex. Anchor) | – Shares | 75% |
| NII Shares Offered | – Shares | 15% |
| Retail Shares Offered | – Shares | 10% |
| Anchor Bidding Date | 2026 |
| Anchor Investors List | |
| Shares Offered | [.] Shares |
| Anchor Size | [.] Cr. |
| lock-in period end date 50% shares (30 Days) | 2026 |
| lock-in period end date 50% shares (90 Days) | 2026 |
| IPO Open Date: | 2026 |
| IPO Close Date: | 2026 |
| Basis of Allotment: | 2026 |
| Refunds: | 2026 |
| Credit to Demat Account: | 2026 |
| IPO Listing Date: | 2026 |
| IPO Bidding Cut-off Time: | 2026 – 5 PM |
| Particular | Shares | % Share |
| Promoter Holding Pre Issue | – | -% |
| Promoter Holding Post Issue | – | -% |
| Purpose | Crores |
| Prepayment or scheduled re-payment of a portion of certain outstanding borrowings availed by the Company. | ₹217.96 |
| Investment in our Subsidiaries, Paras Healthcare (Ranchi) Private Limited and Plus Medicare Hospitals Private Limited, in the form of debt or equity for repayment/prepayment of borrowings, in full or part, of such Subsidiaries. | ₹82.04 |
| General Corporate Purpose | ₹- |
| Period Ended | Revenue | Expense | PAT | Assets |
| 2022 | ₹793.17 | ₹793.46 | ₹14.81 | ₹963.53 |
| 2023 | ₹936.05 | ₹963.11 | ₹42.79 | ₹1,293.1 |
| 2024 | ₹1,151.02 | ₹1,144.39 | ₹15.33 | ₹1,477.66 |
| KPI | Values |
| ROE: | (8.32)% |
| ROCE: | 5.86% |
| EBITDA Margin: | 13.68% |
| PAT Margin: | (1.33)% |
| Debt to equity ratio: | 1.65 |
| Earning Per Share (EPS): | ₹(1.57) (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | (8.32)% |
| Net Asset Value (NAV): | ₹34.68 |
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Apollo Hospitals Enterprise Limited | 62.50 | 106.63 | 16.11% | 429.24 | 19,059.20 Cr. |
| Fortis Healthcare Limited | 7.93 | 64.29 | 17.27% | 52.30 | 6,892.92 Cr. |
| Global Health Limited | 17.80 | 67.64 | 17.96% | 108.01 | 3,275.11 Cr. |
| Jupiter Lifeline Hospitals Limited | 28.65 | 45.95 | 23.09% | 177.93 | 1,095.48 Cr. |
| Krishna Institute of Medical Sciences Limited | 38.75 | 55.57 | 20.53% | 215.00 | 2,498.14 Cr. |
| Max Healthcare Group | 10.89 | 87.50 | 41.69% | 29.07 | 6,849.00 Cr. |
| Narayana Health Limited | 38.86 | 32.08 | 35.22% | 128.90 | 5,018.25 Cr. |
| Yatharth Hospital and Trauma Care Services Limited | 14.46 | 31.97 | 24.06% | 94.89 | 670.55 Cr. |
| IPO Open Date | 2026 |
| IPO Close Date | 2026 |
| Face Value | ₹1 Per Equity Share |
| IPO Price Band | ₹[.] to ₹[.] Per Share |
| Issue Size | Approx ₹[.] Crores |
| Fresh Issue | Approx ₹400 Crores |
| Offer for Sale: | Approx 1,49,74,010 Equity Shares |
| Issue Type | Book Build Issue |
| IPO Listing | BSE, NSE |
| DRHP Draft Prospectus | |
| RHP Draft Prospectus |